Health knowledge and news provided by doctors.

Novartis Recalls Excedrin, NoDoz: What’s In Your Bottle?

Novartis recall headache

When is an aspirin really a caffeine pill or vice versa? When the pills accidentally get into the wrong bottles. Novartis Consumer Health Inc. has voluntarily recalled select bottles of Excedrin®, NoDoz®, Bufferin®, and Gas-X Prevention® as a precaution because the bottles may contain pills from other Novartis products, or broken or chipped tablets.

What’s in your bottle?

If you have the following Novartis products in your medicine cabinet, the company is requesting that you stop using them immediately and contact their Consumer Relationship Center (1-888-477-2403; Monday-Friday 9 AM to 8 PM Eastern time) for information on how to return the product and to receive a full refund. The full list of products can be seen on the Novartis OTC Consumer Products Updates website.

A partial list of the products in this nationwide recall includes

  • All Gas-X Prevention products with an expiration date of December 20, 2013. Gas-X Prevention is a dietary supplement product
  • All NoDoz products with an expiration date of December 20, 2014 or earlier
  • All Bufferin products with an expiration date of December 20, 2013, including Bufferin Extra Strength Tablets, Bufferin Low Dose Tablets, and Bufferin Regular Strength Tablets
  • Selected Excedrin products with an expiration date of December 20, 2014 or earlier. A partial list includes Excedrin Extra Strength Caplets, Excedrin Back & Body Caplets, Excedrin Migraine Caplets, and 13 others (see Excedrin product recall list here)

At this point, Novartis is not aware of anyone who has experienced any adverse effects related to the issues in this recall.

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

Consumers should be aware that accidentally taking an incorrect product (e.g., taking a caffeine pill rather than an aspirin) or taking a higher or lower strength of a product than intended may result in an allergic reaction, an overdose, or interactions with other medications consumers may be taking.

If you have experienced any problems after taking any of these products, contact your healthcare provider. Consumers can also report the adverse event to the Novartis Consumer Relationship Center at 1-888-477-2403.

Novartis has voluntarily and temporarily suspended product and distribution of the Excedrin, Bufferin, NoDoz, and Gas-X products from its Lincoln, Nebraska facility while the matter is being remedied. The recall is being undertaken with the knowledge of the Food and Drug Administration (FDA).

Food and Drug Administration
Novartis Consumer Health Inc.

Picture credit: Wikimedia Commons